Prendergast G C, Hopewell R, Gorham B J, Ziff E B
Howard Hughes Medical Institute, Kaplan Cancer Center, New York, New York.
Genes Dev. 1992 Dec;6(12A):2429-39. doi: 10.1101/gad.6.12a.2429.
In Ras cotransformation assays, Max exhibited a biphasic effect on Myc transformation activity. Cotransfection of low levels of Max expression plasmid stimulated Myc transformation activity, but cotransfection of high levels suppressed it. Mutations in the functionally undefined Max amino- and carboxy-terminal regions outside of the B/HLH/LZ motif partly separated these activities, suggesting various modes of Max regulation. We demonstrate that the Max protein is a nuclear protein in vivo and identify a carboxy-terminal region similar to nuclear localization signals whose integrity is necessary for efficient localization. Two mutants that delete amino- or carboxy-terminal consensus signals for casein kinase II (CKII) exhibited altered gel mobility and DNA-binding potential in vitro and showed modified transforming potential in the Ras cotransformation assay, suggesting that CKII or a CKII-related enzyme may regulate Max function in vivo. Our data suggest that both the ratio of Myc/Max hetero-oligomers to Max homo-oligomers and Max-specific regulation can contribute to determining the biological activity of Myc in vivo.
在Ras共转化试验中,Max对Myc转化活性呈现双相效应。低水平Max表达质粒的共转染刺激了Myc转化活性,但高水平的共转染则抑制了它。B/HLH/LZ基序之外功能未明的Max氨基末端和羧基末端区域的突变部分分离了这些活性,提示了Max的多种调控模式。我们证明Max蛋白在体内是一种核蛋白,并鉴定出一个类似于核定位信号的羧基末端区域,其完整性对于有效定位是必需的。两个缺失酪蛋白激酶II(CKII)氨基末端或羧基末端共有信号的突变体在体外表现出改变的凝胶迁移率和DNA结合潜能,并且在Ras共转化试验中显示出改变的转化潜能,提示CKII或一种与CKII相关的酶可能在体内调节Max功能。我们的数据表明,Myc/Max异源寡聚体与Max同源寡聚体的比例以及Max特异性调控都可能有助于确定Myc在体内的生物学活性。